Neuropathy as an adverse effect of proteasomal inhibitors in multiple myeloma treatment: a network meta-analysis

被引：0

作者：

Garg, Anisha ^{[1
]}

Das, Avash ^{[2
]}

Dasgupta, Subhajit ^{[2
]}

Kumar, Shaji ^{[3
]}

Roy, Bhaskar ^{[1
]}

机构：

[1] Yale Univ, New Haven, CT USA

[2] UT SouthWestern, Dallas, TX USA

[3] Mayo Clin, Rochester, MN USA

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000202155

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P11-8.004

引用

页数：3

共 50 条

[21] Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
Botta, Cirino
Martino, Enrica Antonia
Conticello, Concetta
Mendicino, Francesco
Vigna, Ernesto
Romano, Alessandra
Palumbo, Giuseppe Antonio
Cerchione, Claudio
Martinelli, Giovanni
Morabito, Fortunato
Di Raimondo, Francesco
Gentile, Massimo
FRONTIERS IN ONCOLOGY, 2021, 11
[22] Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis
Arcuri, Leonardo Javier
Americo, Andre Dias
ANNALS OF HEMATOLOGY, 2021, 100 (03) : 725 - 734
[23] Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis
Dan Wu
Feiqing Wang
Xu Yang
Bo Yang
Juan Chen
Jinyang Cheng
Bo Wei
Xiaoshuang Yuan
Tingting Tian
Zhenhua Liu
Zhixu He
Yang Liu
Yanju Li
Discover Oncology, 16 (1)
[24] Impaired proteasomal capacity as the target of proteasome inhibitors in multiple myeloma
Cenci, S
Mezghrani, A
Cascio, P
Oliva, L
Orsi, A
Cerruti, F
Masciarelli, S
Mattioli, L
Pasqualetto, E
Sitia, R
BONE, 2005, 36 : S215 - S216
[25] Efficacy of first-line treatment options in transplant-ineligible multiple myeloma: A network meta-analysis
Kiss, Szabolcs
Gede, Noemi
Soos, Alexandra
Hegyi, Peter
Nagy, Bettina
Imrei, Marcell
Czibere, Bernadett
Farkas, Nelli
Hanak, Lilla
Szakacs, Zsolt
Eross, Balint
Alizadeh, Hussain
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
[26] Ixazomib-associated cardiovascular adverse events in multiple myeloma: a systematic review and meta-analysis
Ling, Yiwen
Li, Rui
Zhong, Jiankai
Zhao, Ying
Chen, Zhuowen
DRUG AND CHEMICAL TOXICOLOGY, 2022, 45 (04) : 1443 - 1448
[27] Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis
Wang, Yin
Li, Yanqing
Chai, Ye
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
[28] Maintenance Treatment and Survival in Patients With Myeloma A Systematic Review and Network Meta-analysis
Gay, Francesca
Jackson, Graham
Rosinol, Laura
Holstein, Sarah A.
Moreau, Philippe
Spada, Stefano
Davies, Faith
Jose Lahuerta, Juan
Leleu, Xavier
Bringhen, Sara
Evangelista, Andrea
Hulin, Cyrille
Panzani, Ugo
Cairns, David A.
Di Raimondo, Francesco
Macro, Margaret
Liberati, Anna Marina
Pawlyn, Charlotte
Offidani, Massimo
Spencer, Andrew
Hajek, Roman
Terpos, Evangelos
Morgan, Gareth J.
Blade, Joan
Sonneveld, Pieter
San-Miguel, Jesus
McCarthy, Philip L.
Ludwig, Heinz
Boccadoro, Mario
Mateos, Maria-Victoria
Attal, Michel
JAMA ONCOLOGY, 2018, 4 (10) : 1389 - 1397
[29] Adverse events associated with androgen receptor signaling inhibitors in the treatment of prostate cancer: A systematic review and network meta-analysis
Cao, Brent
Kim, Melissa
Reizine, Natalie Marie
Moreira, Daniel
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 317 - 317
[30] Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis
Cao, Brent
Kim, Melissa
Reizine, Natalie M.
Moreira, Daniel M.
EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (03): : 237 - 250

← 1 2 3 4 5 →